Chief Clinical Development Officer
Claudia Berger is Chief Clinical Development Officer at Kinarus. She gained her expertise from more than 15 years in the pharmaceutical industry and is leading all clinical trial projects at Kinarus in collaboration with external vendors. Prior this Ms. Berger headed the clinical trial operations unit at Delenex Therapeutics AG in Zürich. In her former role as Principal Clinical Scientist at Novartis in Basel, she led Clinical Trial Teams responsible for the conduct of global clinical studies encompassing profiling, biomarker and more than 12 proof of concept studies. Further responsibilities addressed the management of Novartis’ early development portfolio as well as 4 associates. Ms. Berger is a pharmacist and obtained her Master of Science degree in Pharmacy at the University Basel. She also holds a Diploma as a University Professional of Advanced Studies in Pharmaceutical Medicine (ECPM Course), also performed at University of Basel.